Sugar Maple Asset Management »

Lineage Cell Therapeutics In shares owned by Sugar Maple Asset Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Sugar Maple Asset Management from 13F filings

Historical chart of Sugar Maple Asset Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Sugar Maple Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Sugar Maple Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $503 1.0k 0.50

More positions owned by Sugar Maple Asset Management

Abbvie (ABBV)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr Core S&p500 Etf (IVV)
Abbott Laboratories (ABT)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Silver Tr Ishares (SLV)
Vaneck Etf Trust Clo Etf (CLOI)
T Rowe Price Etf Cap Appreciation (TCAF)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Specialized Funds Div App Etf (VIG)
Fidelity Covington Trust Divid Etf Risi (FDRR)
Pacer Fds Tr Swan Sos Fd Of (PSFF)
Spdr Series Trust S&p Divid Etf (SDY)

View all positions for Sugar Maple Asset Management

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In